BSE filing, NSE: BOMOXY-B1. Summary written from the filing by ALFA Finder's alert engine.
Bombay Oxygen Investments Ltd: key numbers
- Share price
- ₹16,700.00
- Market cap
- ₹250.5 Cr
- Revenue (annual)
- ₹-1.96 Cr
- Net profit (annual)
- ₹-3.24 Cr
- P/E (TTM)
- 238.6×Sector 19.7×
- Promoter holding
- 73.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bombay Oxygen Investments Ltd
All →Bombay Oxygen Investments Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is in compliance with SEBI listing regulations.
Bombay Oxygen Investments Annual General Meeting
Bombay Oxygen Investments Limited conducted its 65th Annual General Meeting on August 25, 2026. Shareholders considered the adoption of financial statements and the declaration of a dividend.
Bombay Oxygen Investments Regulatory Approval
Bombay Oxygen Investments is applying to the RBI for voluntary surrender of its NBFC Certificate of Registration. The company will continue operations as an unregistered NBFC.
Bombay Oxygen Investments Other Announcement
Bombay Oxygen Investments Ltd will apply to the RBI to voluntarily surrender its NBFC Certificate of Registration. The company expects no material impact on business operations.
Bombay Oxygen Investments Q1 FY27 Results: Net Profit ₹28.5 Cr, Up 17.8% YoY
Bombay Oxygen Investments Ltd reported revenue from operations of ₹33.6 Cr (+16.3% YoY) and net profit of ₹28.5 Cr (+17.8% YoY) for Q1 FY27.
- Key figure
- Net profit ₹28.5 Cr · +17.8% YoY
Bombay Oxygen Investments Board Meeting Date
Bombay Oxygen Investments Ltd has scheduled a board meeting for August 10, 2026. The board will consider and approve unaudited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Augmont Enterprises Board Meeting Date
Augmont Enterprises scheduled a Board meeting for November 4, 2026, to approve unaudited Q1 and H1 financial results. Trading window remains closed until 48 hours post-declaration.
Linc Board Meeting Date
Linc Ltd announced that its Board of Directors meeting is scheduled for 5 November 2026. The agenda includes approval of unaudited financial results for Q1 and H1 FY27.
NDR Auto Components Board Meeting Date
NDR Auto Components intimated its board meeting for November 4, 2026, to approve Q1 and H1 FY27 results. No financial figures are reported.
Reliance Chemotex Industries Board Meeting Date
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.
Andhra Sugars Board Meeting Date
The Andhra Sugars Limited intimated a board meeting on 07 Nov 2026 to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes 09 Nov 2026.
Inventure Growth & Securities Board Meeting Date
Inventure Growth & Securities Limited intimated a board meeting on 03 Nov 2026 to consider unaudited standalone and consolidated quarterly financial results for September 2026. Trading window closes 06 Nov 2026.